The CCI has cleared the proposals of 360 ONE and Claypond Capital to jointly purchase stakes in healthtech unicorn PharmEasy.

From high hopes of an INR 6,250 Cr IPO to its current beleaguered state — PharmEasy’s fortunes have swung wildly in less than a year Inc42 has learnt that the company has reduced its workforce ...